Astellas Partnership Offsets Ceftobiprole Setback for Basilea
By PharmaDeals Analyst
Pharma Deals Review: Vol 2010 Issue 3 (Table of Contents)
Published: 15 Mar-2010
DOI: 10.3833/pdr.v2010.i3.1320 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
Basilea Pharmaceutica’s antifungal candidate isavuconazole is at the centre of a significant partnership with Astellas Pharma...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS